The role of in vitro methods as alternatives to animals in toxicity testing

Bibliography

• Roggen EL. In vitro toxicity testing in the twenty-first century. Front Pharmaco 2011;2(3):1-3
   PubMedGoogle Scholar
• Russel WMS, Burch RL. The principles of humane experimental technique. London: Methuen, 1959. Available from: http://altweb.jhsph.edu/pubs/books/humane_exp/het-toc
   Google Scholar
• Franco N, Olsson I. Scientists and the 3Rs: attitudes to animal use in biomedical research and the effect of mandatory training in laboratory animal science. Lab Anim 2013; [Epub ahead of print]
   PubMedGoogle Scholar
• Kinsner-Ovaskainen A, Akkan Z, Casati S, et al. Overcoming barriers to validation of non-animal partial. Replacement methods/integrated testing strategies: the report of an EPAA–ECVAM workshop. ATLA 2009;37:437-44
   Google Scholar
• Kinsner-Ovaskainen A, Maxwell G, Kreysa J, et al. Report of the EPAA-ECVAM workshop on the validation of integrated testing strategies (ITS). Altern Lab Anim 2012;40(3):175-81
   PubMed Web of Science ®Google Scholar
• EPAA. Flash report: integrated testing strategies workshop. 2011. Available from: http://www.ec.europa.eu/enterprise/epaa/2_activities/2_3_comm_and_dissem/its-flash-report.pdf
   Google Scholar
• Berg N, De Wever B, Fuchs HW, et al. Toxicology in the 21st century - Working our way towards a visionary reality. Toxicol In Vitro 2011;25:874-81
   PubMed Web of Science ®Google Scholar
• Louisse J, Verwei M, Woutersen RA, et al. Toward in vitro biomarkers for developmental toxicity and their extrapolation to the in vivo situation. Expt Opin Drug Metab Toxicol 2012;8(1):11-27
   PubMed Web of Science ®Google Scholar
• NRC. Committee on Toxicity Testing and Assessment of Environmental Agents, Board of Environmental Studies and Toxicology, Institute for Laboratory Animal Research. Toxicity testing in the 21st century. A vision and a strategy. National Academies Press; Washington, DC: 2007
   Google Scholar
• Valerio LG Jr. In silico toxicology for the pharmaceutical sciences. Toxicol Appl Pharmacol 2009;241:356-70
   PubMed Web of Science ®Google Scholar
• Blaauboer BJ, Barratt MD, Houston JB. ECVAM workshop report 37. ATLA 1999;27:539-77
   Google Scholar
• Vink SR, Mikkers J, Bouwman T, et al. Use of read-across and tiered exposure assessment in risk assessment under REACH – A case study on a phase-in substance. Reg Toxicol Pharmacol 2010;58:64-71
   PubMed Web of Science ®Google Scholar
• De Wever B, Fuchs HW, Gaca M, et al. Implementation challenges for designing Integrated In Vitro Testing Strategies (ITS) aiming at reducing and replacing animal experimentation. Toxicol In Vitro 2012;26:526-34
   PubMed Web of Science ®Google Scholar
• NRC. Committee on Applications of Toxicogenomic Technologies to Predictive Toxicology, Board of Environmental Studies and Toxicology, Board of Life Studies, Division of Earth and Life Studies. Applications of Toxicogenomic Technologies to Predictive Toxicology and Risk Assessment. National Academies Press; Washington, DC: 2007
   Google Scholar
• van Vliet E. Current standing and future prospects for the technologies proposed to transform toxicity testing in the 2st century. ALTEX 2011;28(1):17-44
   PubMedGoogle Scholar
• Hartung T. From alternative methods to a new toxicology. Eur J Pharm Biopharm 2011;77:338-49
   PubMed Web of Science ®Google Scholar
• Combes RD, Balls M. Integrated testing strategies for toxicity employing new and existing technologies. ATLA 2011;39:213-25
   Google Scholar
• Spieldmann H, Balls M, Dupuy J, et al. Study on the UV filter chemical from Annex VII of European union directive 76/768/EEC, in the in vitro 3T3 NRU phototoxicity test. Altern Lab Anim 1998;26:679
   PubMed Web of Science ®Google Scholar
• Fentem JH, Archer GE, Balls M, et al. The ECVAM international validation study on in vitro test for skin corrosivity 2. Results and evaluation by the Management Teal. Toxicol In Vitro 1998;12:483-524
   PubMed Web of Science ®Google Scholar
• OECD. TG 405 ‘‘Acute eye irritation/corrosion'', adopted October 2nd 2002, including a supplement to TG 405 entitled. A sequential testing strategy for eye irritation and, corrosion. p. 9-13
   Google Scholar
• OECD. TG 404 ‘‘Acute dermal irritation/corrosion'', adopted April 24th 2002, including a supplement to TG 404 entitled. A sequential testing strategy for dermal irritation and, corrosion. p. 11-14
   Google Scholar
• Djabari Z, Bauza E, Dal C, et al. The HET-CAM test combined with histological studies for better evaluation of active ingredient innocuity. Int J Tissue React 2002;24:117-21
   PubMedGoogle Scholar
• Adler S, Basketter D, Creton S, et al. Alternative (non-animal) methods for cosmetics testing: current status and future prospects-2010. Arch Toxicol 2011;85(5):367-485
   PubMed Web of Science ®Google Scholar
• Bissell MJ, Rizki A, Mian IS. Tissue architecture: the ultimate regulator of breast epithelial function. Curr Opin Cell Biol 2003;15:753-62
   PubMed Web of Science ®Google Scholar
• Debnath J, Brugge JS. Modelling glandular epithelial cancers in three-dimensional cultures. Nat Rev Cancer 2005;5:675-88
   PubMed Web of Science ®Google Scholar
• Cooper JF. Principles and applications of the limulus test for pyrogen in parenteral drugs. Bull Parent Drug Assoc 1975;3:127-33
   Google Scholar
• OECD. Series on testing and assessment No. 88. ‘‘Report from the workshop on integrated approaches to testing and assessment'' held in ITS. 2007.
   Google Scholar
• OECD. Guidance document on the validation and international acceptance of new or updated test methods for hazard assessment, series on testing and assessment, No. 34. OECD; Paris: 2005
   Google Scholar
• Balls M, Blaauboer BJ, Fentem JH, et al. Practical aspects of the validation of toxicity test procedures. The report and recommendations of ECVAM workshop 5. ATLA 1995;23:129-47
   Google Scholar
• Hartung T, Bremer S, Casati S, et al. A modular approach to the ECVAM principles on test validity. Altern Lab Anim 2004;32:467-72
   PubMed Web of Science ®Google Scholar
• Anadón A, Martínez-Larrañaga MR, Castellano V. Chapter 55. Biomarkers in drug safety evaluation: European perspective. In: Biomarkers in toxicology. Gupta RC, editor. Elsevier/Academic Press; San Diego, CA, USA: 2014; p. 923-45
   Google Scholar
• Polanski M, Anderson NL. A list of candidate cancer biomarkers for targeted proteomics. Biomark Insights 2006;1:1-48
   Google Scholar
• Krewski D, Andersen ME, Mantus E, Zeise L. Toxicity testing in the 21st century: implications for human health risk assessment. Risk Anal 2009;29(4):474-9
   PubMed Web of Science ®Google Scholar
• Blaauboer BJ, Boekelheide K, Clewell HJ, et al. The use of biomarkers of toxicity for integrating in vitro hazard estimates into risk assessment for humans. ALTEX 2012;29(4):411-25
   PubMedGoogle Scholar
• Eisenbrand G, Pool-Zobel B, Baker V, et al. Methods of in vitro toxicology. Food Chem Toxicol 2002;40:193-236
   PubMed Web of Science ®Google Scholar
• Basketter DA, Clewell H, Kimber I, et al. A roadmap for the development of alternative (non-animal) methods for systemic toxicity testing. ALTEX 2012;29:3-91
   PubMedGoogle Scholar
• Tralau T, Riebeling C, Pirow R, et al. Wind of change challenges toxicological regulators. Environ Health Perspect 2012;120(11):1489-94
   PubMed Web of Science ®Google Scholar
• Wilmes A, Limonciel A, Aschauer L, et al. Application of integrated transcriptomic, proteomic and metabolomic profiling for the delineation of mechanisms of drug induced cell stress. J Proteomics 2013;79:180-94
   PubMed Web of Science ®Google Scholar
• Renwick AG, Lazarus NR. Human variability and non-cancer risk assessment – An analysis of the default uncertainty factor. Regul Toxicol Pharmacol 1998;27:3-20
   PubMed Web of Science ®Google Scholar
• Clewell HJ, Andersen ME, Blaauboer BJ. On the incorporation of chemical-specific information in risk assessment. Toxicol Lett 2008;180:100-9
   PubMed Web of Science ®Google Scholar
• Blaauboer BJ. Biokinetic modeling and in vitro-in vivo extrapolations. J Toxicol Environ Health B Crit Rev 2010;13:242-52
   PubMed Web of Science ®Google Scholar
• Blaauboer BJ. The contribution of in vitro toxicity data in hazard and risk assessment: current limitations and future perspectives. Toxicol Lett 2008;180:81-4
   PubMed Web of Science ®Google Scholar
• Krewski D, Andersen ME, Mantus E, Zeise L. Toxicity testing in the 21st century implications for human health risk assessment. Risk Anal 2009;29(4):474-9
   PubMed Web of Science ®Google Scholar
• Andersen ME. Toxicokinetics modeling and its applications in chemical risk assessment. Toxicol Lett 2003;138:9-27
   PubMed Web of Science ®Google Scholar
• Ambache N, Anadón A, Martínez-Larrañaga MR. Extraction and partial purification of spasmogenic substances in Auerbach's plexus. Arch Int Pharmacodyn Ther 1986;281(1):145-68
   PubMedGoogle Scholar
• Anadón A, Martínez-Larrañaga MR. An inhibitory action of tetracyclines on guinea-pig myenteric plexus. Naunyn-Schmiedeberg's Arch Pharmacol 1987;335:200-3
   Google Scholar
• Romero A, Ramos E, Castellano V, et al. Cytotoxicity induced by deltamethrin and its metabolites in SH-SY5Y cells can be differentially prevented by selected antioxidants. Toxicol In Vitro 2012;26:823-30
   PubMed Web of Science ®Google Scholar
• EFSA. Technical Guidance for establishing the safety of additives for the consumer. Prepared by the Panel on Additives and Products or Substances used in Animal Feed (Question No EFSA-Q-2008-406), Adopted on 16 September. EFSA J 2008;801:1-12
   Google Scholar
• EMEA. ICH Topic S7A. Note for guidance on safety pharmacology studies for human pharmaceuticals (CPMP/ICH/539/00) June 2001
   Google Scholar
• Rostami-Hodjegan A, Tucker GT. Simulation and prediction of in vivo drug metabolism in human populations from in vitro data. Nat Rev Drug Discov 2007;6:140-8
   PubMed Web of Science ®Google Scholar